By Abhishek Singhh | Published on abhishekschauhan.com
As seen on: ANI News · Outlook Business · The Print · News X · The Tribune · MSN · The Daily Guardian
You wake up exhausted after eight hours of sleep. Your hair is coming out in the shower — more than it used to, noticeably more. You have gained weight without meaningfully changing what you eat. You feel cold when everyone around you is comfortable. Your mood is flat. Your concentration is poor. Your periods have changed.
You went to your doctor. They ran some tests. Everything came back “normal.” They said it was probably stress. Maybe anxiety. Maybe perimenopause. Maybe you just need more exercise.
You went home and Googled your symptoms at 11pm. Every result said the same thing: thyroid.
You are not imagining this. Millions of Indian women between 35 and 55 are living exactly this experience — with a thyroid condition that is either undetected, misdiagnosed, or undertreated. And the system they are relying on to find it is consistently failing them.
The Scale of the Problem India Is Not Taking Seriously Enough
42 million Indians are estimated to suffer from thyroid disorders. It is one of the most prevalent endocrine conditions in the country — more common than most people realise, because its symptoms are so easily attributed to everything else.
Data published just days ago from Mahajan Imaging and Labs, covering thyroid blood investigations conducted between April 2025 and April 2026, found that 14% to 22% of all thyroid function tests returned abnormal results. Not borderline. Abnormal. Nearly one in five people who walked in for a thyroid test had a measurable thyroid dysfunction.
More striking: a recent study found that 51% of apparently healthy young Indians living in delhi have undetected thyroid abnormalities — elevated TSH, abnormal T3/T4 levels, or positive anti-TPO antibodies — without any formal diagnosis. They have never been told. They are walking around with a condition that is quietly disrupting their metabolism, immune system, mood, and hormonal balance, while being reassured that their fatigue and weight gain are just life.
Women are nearly 10 times more likely than men to develop a thyroid imbalance. The peak prevalence of hypothyroidism in India occurs precisely in the 46–54 age group, affecting 13.11% of women in that bracket. For women in perimenopause — already navigating hormonal fluctuation — an undetected thyroid condition compounds every symptom and makes the clinical picture almost impossible to read without the right tests.
The thyroid epidemic in India is not a niche endocrinology story. It is one of the most widespread, most searched, and most under-addressed health crises affecting women in their most demanding decades.
What the Thyroid Actually Does — and Why Its Failure Is So Invisible
The thyroid gland sits at the base of your neck, small enough that most people are unaware of its existence until something goes wrong. Its job is to produce thyroid hormones — primarily T4 (thyroxine) and T3 (triiodothyronine) — that regulate metabolism in virtually every cell of the body.
Every cell. Not some cells. Every cell.
This is why thyroid dysfunction produces symptoms across so many systems simultaneously. The thyroid does not control one organ. It controls the metabolic rate of all of them. When it underproduces — hypothyroidism — everything slows down. Digestion slows. Cognition slows. Heart rate slows. Hair growth cycles slow. Energy production slows. The gut slows to the point of chronic constipation. The skin thickens and dries. The metabolism drops and weight accumulates even on a normal diet.
This broad systemic effect is precisely why hypothyroidism is so commonly missed. A doctor sees fatigue and thinks depression. They see weight gain and suggest diet changes. They see hair loss and recommend a dermatologist. They see constipation and prescribe a fibre supplement. Each symptom is routed to a separate specialist while the underlying cause — a small, underperforming butterfly-shaped gland in the neck — continues to slow everything down.
The woman sitting across from this fragmented system has typically been experiencing symptoms for two to five years before receiving a correct diagnosis. On health forums across India and globally, this story repeats with extraordinary consistency. “I was told it was stress for three years.” “My doctor said it was just perimenopause.” “They kept saying my TSH was normal and dismissed me.” “I finally pushed for a full panel and my antibodies were off the charts.”
This is not a rare edge case. This is the median experience.
The TSH Problem: Why “Normal” May Not Mean Fine
This is the most important section in this article for anyone who has been told their thyroid test is normal but still has symptoms.
The standard thyroid test ordered in India — and globally — is TSH (thyroid stimulating hormone). TSH is produced by the pituitary gland to tell the thyroid to produce more hormone. When the thyroid underperforms, TSH rises. When it overperforms, TSH falls.
The “normal” TSH range used by most Indian labs is approximately 0.5 to 5.0 mIU/L. A reading within this range is reported as normal and the conversation typically ends there.
Two problems with this.
The reference range is too wide for clinical utility. The 0.5–5.0 range was derived from population averages that include people with subclinical thyroid dysfunction. Many endocrinologists — including the guidelines of the American Association of Clinical Endocrinologists and a growing body of Indian endocrinology literature — consider the functionally optimal TSH range to be 0.5 to 2.5 mIU/L. A woman with a TSH of 4.2 falls within the lab’s “normal” range but may be experiencing significant symptoms that would resolve with treatment. She is told she is fine. She is not fine.
TSH alone is an incomplete picture. TSH tells you what the pituitary is signalling. It does not tell you how much active thyroid hormone is actually in circulation, whether T4 is being converted to active T3, or whether the immune system is attacking the thyroid. A complete thyroid assessment requires:
Free T4 — the storage hormone circulating in the blood.
Free T3 — the active hormone that actually enters cells and drives metabolism. T4 must be converted to T3, primarily in the liver and gut. This conversion can be impaired by chronic stress, gut dysbiosis, selenium deficiency, and inflammation — all of which are endemic in urban India.
Anti-TPO antibodies — the marker for Hashimoto’s thyroiditis, the autoimmune condition that is the most common cause of hypothyroidism in India. A person can have normal TSH and elevated anti-TPO antibodies — meaning the immune system is actively attacking the thyroid but the damage has not yet progressed far enough to show up in TSH. These people are often told they are fine.
Anti-thyroglobulin antibodies — a second autoimmune marker that provides a more complete picture of immune activity against the thyroid.
The standard practice of running TSH alone and reporting “normal” on a result of 3.8 or 4.1 is leaving millions of symptomatic Indian women undiagnosed and untreated. It is not malicious. It is systemic — the product of an overloaded healthcare system defaulting to the cheapest, fastest screen while the full picture goes unread.
Hashimoto’s: The Word Your Doctor May Never Have Said
Hashimoto’s thyroiditis is the most common cause of hypothyroidism in India. It is an autoimmune condition in which the immune system produces antibodies that attack the thyroid gland, progressively impairing its function over years.
It is significantly underdiagnosed in India because the standard TSH-only screening misses it in the early stages.
The symptoms of early Hashimoto’s are indistinguishable from the general experience of a busy woman in her late 30s or 40s: fatigue, brain fog, hair thinning, weight resistance, mood changes, and joint pain. Because these symptoms are so normalised — because Indian culture runs on the premise that exhausted women are simply coping with the demands of work, family, and social obligation — the threshold for investigating further is set too high.
Hashimoto’s progresses along a spectrum. In the early autoimmune phase, TSH may be completely normal while anti-TPO antibodies are already elevated. The immune attack is underway. The thyroid is being damaged. No diagnosis has been made. No intervention has been offered. The patient lives with symptoms for another two to three years until the TSH finally moves outside the “normal” range and someone pays attention.
There is a direct connection to gut health here that most patients and many clinicians are unaware of. All autoimmune diseases — including Hashimoto’s — have a strong association with gut permeability and microbiome imbalance. Leaky gut allows partially digested food particles to pass into the bloodstream, triggering immune activation that can cross-react with thyroid tissue. A Hashimoto’s patient with untreated gut dysbiosis is fighting the immune attack with one hand while the other hand continues to fuel it.
The gut-thyroid connection also affects treatment. T4 to T3 conversion — the critical metabolic step that produces the active thyroid hormone — is partially dependent on gut bacteria. A compromised microbiome directly impairs this conversion, meaning a person on levothyroxine (T4) who has gut dysbiosis may consistently feel unwell despite “normal” lab numbers because the T4 is not converting efficiently to T3.
This is one of the most commonly reported experiences on thyroid forums globally: “My TSH is in range on medication but I still feel terrible.” The medication is doing what it does. The gut is failing to convert it.
The Cortisol-Thyroid Connection Nobody Discusses
In the context of this series, the thyroid does not stand alone.
Chronic cortisol elevation — which I documented in my article on India’s burnout crisis — directly impairs thyroid function through multiple mechanisms. Elevated cortisol reduces TSH secretion, impairs T4 to T3 conversion, and increases reverse T3 — an inactive form of T3 that occupies T3 receptors without activating them, effectively blocking the active hormone from working.
A chronically stressed Indian professional woman in her 40s with elevated cortisol from burnout, gut dysbiosis from an urban processed diet, vitamin D deficiency (which impairs immune regulation and is associated with higher autoimmune thyroid disease rates), and magnesium deficiency (which impairs thyroid hormone synthesis) is not experiencing separate health problems. She is experiencing one systemic biological disruption expressing itself across the thyroid, the adrenal axis, the gut, and the immune system simultaneously.
This is why the “treat each symptom separately” approach fails so consistently for these patients. The fatigue is not just thyroid. The mood disorder is not just anxiety. The weight gain is not just diet. It is one system, damaged across multiple dimensions, being managed by specialists who are each looking at one panel.
The Selenium and Iodine Story India Has Gotten Wrong
Two nutrients are critically important for thyroid function and are both misunderstood in the Indian context.
Iodine. India historically had widespread iodine deficiency — the primary cause of goitre and hypothyroidism in earlier decades. Mandatory iodisation of salt addressed the deficiency problem. But the relationship between iodine and the thyroid is not simply “more is better.” Excess iodine, particularly in genetically susceptible individuals, can trigger autoimmune thyroid disease by making the thyroid gland more susceptible to immune attack. India has transitioned from iodine deficiency to adequate iodine status — but the rise in Hashimoto’s prevalence in urban areas is partially attributed to this transition and the autoimmune implications of higher iodine availability.
Selenium. Selenium is essential for two processes critical to thyroid health: T4 to T3 conversion, and the antioxidant protection of thyroid cells from the hydrogen peroxide produced during hormone synthesis. The thyroid has the highest concentration of selenium of any organ in the body. Selenium deficiency — which is common in India, particularly in regions with selenium-poor soil — impairs both conversion and cellular protection, worsening both hypothyroidism and autoimmune thyroid disease progression.
Multiple randomised controlled trials have demonstrated that selenium supplementation (200 mcg selenium as selenomethionine daily) meaningfully reduces anti-TPO antibodies in Hashimoto’s patients. This is not alternative medicine. It is evidence-based endocrinology that is dramatically underutilised in clinical practice in India.
Brazil nuts contain among the highest dietary selenium of any food. Two Brazil nuts a day provides approximately 200 mcg selenium. This is both the simplest and most underutilised thyroid intervention in India.
What the Supplement Industry Does With Thyroid Anxiety
“Thyroid support” is one of the fastest-growing supplement categories in India. Every brand in the wellness space now has a thyroid SKU — blends with ashwagandha, guggul, selenium, zinc, iodine, and a rotating cast of herbal ingredients positioned under phrases like “supports healthy thyroid function.”
Some of these ingredients have genuine evidence. Some are included at doses too low to matter. And one — iodine — is a category where supplementing without testing is potentially harmful. Adding iodine to someone who already has adequate iodine intake and an autoimmune thyroid condition may worsen the condition rather than improve it.
The pattern is familiar across every category in this series: an ingredient with real evidence, dosed for the label, combined with others at marketing amounts, sold to a frightened population that deserves specific answers but is being given generalised hope.
Guggul (Commiphora mukul) has Ayurvedic tradition and some modern evidence for supporting thyroid function — specifically, guggulsterones have been shown to stimulate thyroid activity. This makes it potentially appropriate for hypothyroidism and potentially inappropriate for hyperthyroidism — a distinction that virtually no “thyroid support” supplement label addresses.
Ashwagandha has evidence for modestly improving thyroid hormone levels in subclinical hypothyroidism through its effect on stress and HPA axis regulation. But it is an adaptogen, not a thyroid stimulant. It works on the cortisol-thyroid connection, not directly on the gland.
Zinc is required for T4 production and T3 conversion. Deficiency impairs thyroid function. Supplementing in deficient individuals helps. Supplementing in non-deficient individuals adds nothing.
The honest answer for thyroid-related supplementation is the same as for every other category: test first. Know what is actually deficient. Address the deficiency specifically. Do not buy a 12-ingredient blend and hope one of them happens to be what you need at the dose you need it.
What a Proper Thyroid Investigation Actually Looks Like
If you have been experiencing the symptoms described in this article — persistent fatigue, unexplained weight gain, hair thinning, brain fog, cold sensitivity, mood changes, constipation — and have been told your TSH is “normal,” this is the investigation you should request:
Free T3 and Free T4 in addition to TSH. Not total T3/T4 — free levels. The distinction matters clinically.
Anti-TPO antibodies to screen for Hashimoto’s, regardless of TSH level.
Anti-thyroglobulin antibodies as a complementary autoimmune marker.
Selenium level if available at your diagnostic centre.
Vitamin D — low vitamin D is significantly associated with autoimmune thyroid disease, and deficiency is near-universal in urban India.
Ferritin (not just haemoglobin) — iron deficiency impairs T4 to T3 conversion and is extremely common in Indian women of this age group. A woman with “normal” haemoglobin can still have low ferritin that is significantly impairing her thyroid function.
Fasting glucose and insulin — metabolic dysfunction and thyroid dysfunction frequently coexist and amplify each other.
This panel costs between ₹1,500 and ₹3,500 at most diagnostics chains. It tells a complete story rather than a single data point that is too easily labelled “normal” and filed away.
If the results show elevated antibodies with normal TSH — which is common in early Hashimoto’s — find an endocrinologist who will monitor and manage the autoimmune component, not just wait for TSH to deteriorate. Early intervention slows progression. Waiting for TSH to cross the threshold is standard protocol but not optimal care.
The Last Thing This Article Will Say
The women posting in health forums at midnight — describing three years of hair loss, weight gain, and exhaustion while being told they are fine — are not hypochondriacs. They are not anxious women catastrophising normal aging. They are people with a measurable biological dysfunction that a single inadequate test keeps missing.
The thyroid is not mysterious. It is not difficult to test properly. The information to diagnose and manage it well exists in abundance. What is missing is a healthcare encounter long enough, thorough enough, and curious enough to order the full picture instead of defaulting to the screening minimum.
If you recognise yourself in this article, do not wait to be told you are fine again. Request the full panel. Find a doctor who will read it with you. The condition that has been explaining your last three years may be smaller than a walnut and sitting right there in your neck, waiting to be found.
This is part of an ongoing series on what India’s wellness industry gets wrong — and what the evidence actually says. Read the rest of the series: Why Your Supplement Is Lying to You · Indians Are Sleeping More Than Ever. So Why Are They Waking Up Exhausted? · India Has More Sunshine Than Almost Any Country on Earth. So Why Is Half the Population Vitamin D Deficient? · You Are 32 Years Old, Relatively Fit, and Pre-Diabetic · India Is the Most Burned-Out Country on Earth · The Average Indian Has Their First Heart Attack at 53
Abhishek Singhh is the founder of Just What Works™ (Elara Biosciences), JeevRasa, The FarmPURE, ReEarthy, and SuppleFoods — five wellness brands built on one shared belief: the wellness industry has a honesty problem. He writes on supplement science, D2C brand building in India, and Ayurveda as a serious industry.
Follow on LinkedIn
Abhishek Singh is the founder of Just What Works and a passionate entrepreneur in the nutraceutical space. Through his brand and writing, he shares practical business strategies, wellness insights, and real-world lessons from his own startup journey. His work helps readers cut through noise and focus on building businesses — and lives — that truly work.